TNFRSF10A and prostate cancer: The research also confirmed previous observations made by Cheng et al. that the activation of FOXO3a causes an upregulation of Bim, TRAIL, death receptors 4 and 5 (DR4 and DR5), and p27/Kip1 and triggers apoptosis in LNCaP prostate cancer cells [34].